Quantcast
Channel: MassDevice
Browsing all 11515 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Tandem Diabetes to integrate TypeZero’s artificial pancreas tech

Tandem Diabetes Care (NSDQ:TNDM) said today it inked a license agreement with TypeZero Technologies to integrate TypeZero’s artificial pancreas into Tandem’s next-gen t:slim insulin pump. TypeZero’s...

View Article



Image may be NSFW.
Clik here to view.

Sunshine Heart raises $3.5m

Sunshine Heart (NSDQ:SSH) said today it raised $3.5 million in a direct offering to a single investor through the sale of convertible preferred stock. The Eden Prairie, Minn.-based company said it...

View Article

Image may be NSFW.
Clik here to view.

MassDevice.com +5 | The top 5 medtech stories for July 21, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...

View Article

Image may be NSFW.
Clik here to view.

Philips connects Trilogy ventilators to the Internet of Things

Royal Philips (NYSE:PHG) said today its Trilogy family of portable ventilators will be connected to its Care Orchestrator connected care management application. Get the rest of the story at our sister...

View Article

Image may be NSFW.
Clik here to view.

Stryker translates CMS claims data for hospitals

Stryker (NYSE:SYK) said today its Stryker Performance Solutions business unit is now offering a new Episode Performance Manager tool designed to CMS data into actionable data for hospitals. The newly...

View Article


Image may be NSFW.
Clik here to view.

Halyard Health, Belintra ink sterile packaging & logistics pact

Medical technology company Halyard Health (NYSE:HYH) and Belintra, a healthcare logistics provider, will pursue a co-marketing partnership focused on improving the sterility of wrap products before...

View Article

Image may be NSFW.
Clik here to view.

Relievant Medsystems wins FDA clearance for Intracept ablation device for low...

Relievant Medsystems said today it won FDA 510(k) clearance for its Intracept intraosseous nerve ablation system designed for the treatment of chronic lower back pain. The company touted the system as...

View Article

Image may be NSFW.
Clik here to view.

FDA panel votes in favor of Dexcom G5 dosage label expansion

UPDATED July 22, 2016, with comment from Dexcom. An advisory panel recommended today that the FDA grant Dexcom‘s (NSDQ:DXCM) bid for a non-adjuctive dosing claim for its G5 continuous glucose monitor...

View Article


Image may be NSFW.
Clik here to view.

US FDA urges national device evaluation system incorporating UDI

By Stewart Eisenhart, Emergo Group Top US Food and Drug Administration officials are pushing for implementation of a national system for evaluating medical device pre- and post-market data including...

View Article


Image may be NSFW.
Clik here to view.

Stryker’s Q2 numbers top estimates, outlook raised on 2016 sales and earnings

Stryker (NYSE:SYK) shares ticked down in pre-market trading today despite a 2nd consecutive “beat & raise” quarter that saw the medical device giant top both sales and earnings forecasts and boost...

View Article

Image may be NSFW.
Clik here to view.

Profits, sales up during Q2 for GE Healthcare

Profits and sales grew during the 2nd quarter for GE Healthcare (NYSE:GE), helping the industrial conglomerate beat Wall Street’s earnings forecast. GE Healthcare’s operating profits rose 11% to $782...

View Article

Image may be NSFW.
Clik here to view.

Plaintiff’s $8m win in DePuy ASR hip trial survives Johnson & Johnson’s appeal

An $8 million plaintiff’s award in a product liability lawsuit brought over the DePuy ASR XL metal-on-metal hip implant made by Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics survived...

View Article

Image may be NSFW.
Clik here to view.

India’s proposed stent pricing cap said to squash new product introductions

India’s move toward capping the price on coronary stents reportedly has medical device makers rethinking their strategies there and even shelving new product rollouts. “With price controls, margins of...

View Article


Image may be NSFW.
Clik here to view.

Appeals court tosses $20m AngioScore win over TriReme Medical

A federal appeals court yesterday tossed AngioScore‘s $20 million win over TriReme Medical and a pair of related companies, ruling that the case never should have made it to the federal level. Just...

View Article

Image may be NSFW.
Clik here to view.

Natus Medical shares dip on missed Q2 release

Natus Medical (NSDQ:BABY) saw shares fall over 2% yesterday after releasing 2nd quarter earnings that missed the mark on earnings per share and revenue. The Pleasanton, Calif.-based company reported...

View Article


Image may be NSFW.
Clik here to view.

J&J’s Acclarent to pay $18m over off-label marketing charges

Johnson & Johnson (NYSE:JNJ) subsidiary Acclarent will pay $18 million to resolve allegations over false claims submitted to Medicare and other federal health care programs in relation to marketing...

View Article

Image may be NSFW.
Clik here to view.

Prism Medical wins approval for shareholders meeting for sale to Handicare

Prism Medical said today it obtained an interim order from the Ontario Superior Court of Justice to allow for a special meeting of share holders to approve its acquisition by Handicare. The meeting is...

View Article


Image may be NSFW.
Clik here to view.

Direct Flow raises $27 million

Direct Flow Medical raised raised $27.1 million in a new round of financing through the sales of select stock and warrants. Money in the round came from 11 anonymous investors, with the company looking...

View Article

Image may be NSFW.
Clik here to view.

MassDevice.com +5 | The top 5 medtech stories for July 22, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...

View Article

Image may be NSFW.
Clik here to view.

Stealthy early-stage NVision Medical raises $6.5m

Stealthy NVision Medical raised $6.5 million in a new round of equity financing to support its ovarian cancer diagnostic device, according to an SEC filing. NVision is an early-stage medical device...

View Article
Browsing all 11515 articles
Browse latest View live




Latest Images